Literature DB >> 19867607

THE CARBON DIOXIDE CONTENT OF THE BLOOD IN PNEUMONIA.

F W Peabody1.   

Abstract

A diminution in the carbon dioxide content of the blood is a constant feature in pneumonia. Occasional cases, however, may fail to show low carbon dioxide. The carbon dioxide in the blood bears little definite relation to the severity of the disease, except that it tends to be lowest in severe cases and in the terminal stages of the disease. There is less deviation from the normal in short or mild cases. The diminution in the carbon dioxide in the blood bears no immediate relation to temperature, as it may persist for some days after the patient is afebrile. The diminution in carbon dioxide corresponds to the other evidences of metabolic changes in infection and, like them, may be even greater after than during the febrile period. The changes in the carbon dioxide content of the blood run parallel to the output of ammonia in the urine. The carbon dioxide appears to bear no relation to chlorine excretion. In two unusual cases the carbon dioxide content of the blood was normal or above normal. This was associated with a very low oxygen content of the venous blood.

Entities:  

Year:  1912        PMID: 19867607      PMCID: PMC2124990          DOI: 10.1084/jem.16.5.701

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  The Cause and the Control of Dyspnœa in Disease of the Lungs.

Authors:  G W Norris
Journal:  Trans Am Climatol Clin Assoc       Date:  1921

2.  OBSERVATIONS ON BLOOD REACTION IN EXPERIMENTAL PNEUMONIA.

Authors:  C D Leake; J L Vickers; T K Brown
Journal:  J Exp Med       Date:  1924-02-29       Impact factor: 14.307

3.  ACIDOSIS AND ACID EXCRETION IN PNEUMONIA.

Authors:  W W Palmer
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307

4.  THE OXYGEN AND CARBON DIOXIDE CONTENT OF ARTERIAL AND OF VENOUS BLOOD IN NORMAL INDIVIDUALS AND IN PATIENTS WITH ANEMIA AND HEART DISEASE.

Authors:  G A Harrop
Journal:  J Exp Med       Date:  1919-09-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.